As we known, the proapoptotic effects of ASPP2 is tightly linked to its tumour‐suppression function in many animal cancer models including renal carcinoma.32, 33 However, whether ASPP2 participates in renal injury remains to be further explored. Here, TP53BP2 is linked to renal carcinoma.